
Cantel Medical Corp. Market Cap 2011-2025 | CMD
As of December 15, 2025 Cantel Medical Corp. has a market cap of $ 3.4 B
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap Cantel Medical Corp.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 2.27 B | 3.84 B | 3.98 B | 3.28 B | 3.14 B | 2.08 B | 1.49 B | 1.07 B | 707 M | 425 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.98 B | 425 M | 2.23 B |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical instruments industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
BioLife Solutions
BLFS
|
1.14 B | $ 24.39 | - | $ 1.12 B | ||
|
Baxter International
BAX
|
17.3 B | $ 19.68 | 2.77 % | $ 10 B | ||
|
Becton, Dickinson and Company
BDX
|
56.2 B | $ 200.26 | -0.34 % | $ 57.6 B | ||
|
Luminex Corporation
LMNX
|
1.27 B | - | - | $ 1.75 B | ||
|
Akers Biosciences, Inc.
AKER
|
809 K | - | -9.52 % | $ 20.6 M | ||
|
Ekso Bionics Holdings
EKSO
|
9.68 M | $ 4.68 | 0.21 % | $ 94.4 M | ||
|
Antares Pharma, Inc.
ATRS
|
727 M | - | - | $ 955 M | ||
|
CRH Medical Corporation
CRHM
|
152 M | - | - | $ 282 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
6.07 B | - | -0.05 % | $ 10.3 B | ||
|
Harvard Bioscience
HBIO
|
188 M | $ 0.71 | -3.6 % | $ 30.1 M | ||
|
Varian Medical Systems, Inc.
VAR
|
15.6 B | - | -0.02 % | $ 16.3 B | ||
|
ICU Medical
ICUI
|
3.65 B | $ 147.79 | -0.43 % | $ 3.6 B | ||
|
Alcon
ALC
|
42.6 B | $ 79.23 | 0.53 % | $ 40.4 B | ||
|
iRhythm Technologies
IRTC
|
3.49 B | $ 171.52 | 1.59 % | $ 5.35 B | ||
|
AtriCure
ATRC
|
1.91 B | $ 41.41 | -2.29 % | $ 1.94 B | ||
|
Atrion Corporation
ATRI
|
639 M | - | - | $ 810 M | ||
|
electroCore
ECOR
|
29.4 K | $ 4.8 | 1.05 % | $ 26.5 K | ||
|
Repro Med Systems
KRMD
|
96.7 M | $ 5.8 | 0.35 % | $ 264 M | ||
|
AngioDynamics
ANGO
|
355 M | $ 13.38 | 1.83 % | $ 547 M | ||
|
The Cooper Companies
COO
|
16.3 B | $ 81.12 | -1.17 % | $ 16.2 B | ||
|
LeMaitre Vascular
LMAT
|
2.07 B | $ 83.58 | -0.5 % | $ 1.88 B | ||
|
Glaukos Corporation
GKOS
|
4.3 B | $ 111.86 | 2.72 % | $ 5.42 B | ||
|
Haemonetics Corporation
HAE
|
3.06 B | $ 78.81 | -5.6 % | $ 3.97 B | ||
|
InfuSystem Holdings
INFU
|
146 M | $ 9.18 | -0.65 % | $ 190 M | ||
|
Masimo Corporation
MASI
|
8.96 B | $ 136.6 | -1.25 % | $ 7.28 B | ||
|
Isoray
ISR
|
24.5 M | - | 0.03 % | $ 108 M | ||
|
Merit Medical Systems
MMSI
|
5.94 B | $ 85.98 | -0.83 % | $ 5.01 B | ||
|
Intuitive Surgical
ISRG
|
203 B | $ 554.57 | 2.26 % | $ 197 B | ||
|
OraSure Technologies
OSUR
|
259 M | $ 2.48 | -0.25 % | $ 185 M | ||
|
Microbot Medical
MBOT
|
11.7 M | $ 2.25 | -6.64 % | $ 22.9 M | ||
|
Milestone Scientific
MLSS
|
69.4 M | $ 0.37 | -5.12 % | $ 29.5 M | ||
|
Nephros
NEPH
|
22.5 M | $ 4.96 | -1.29 % | $ 51.5 M | ||
|
NeuroMetrix
NURO
|
8.71 M | - | 5.05 % | $ 9.02 M | ||
|
Envista Holdings Corporation
NVST
|
3.68 B | $ 22.01 | 0.16 % | $ 3.79 B | ||
|
ResMed
RMD
|
35.1 B | $ 252.48 | 0.05 % | $ 36.9 B | ||
|
Pro-Dex
PDEX
|
150 M | $ 42.14 | -2.86 % | $ 139 M | ||
|
STAAR Surgical Company
STAA
|
832 M | $ 23.59 | -2.24 % | $ 1.16 B | ||
|
STERIS plc
STE
|
24.2 B | $ 252.72 | 0.32 % | $ 24.9 B | ||
|
Stereotaxis
STXS
|
215 M | $ 2.36 | -0.42 % | $ 190 M | ||
|
Pulse Biosciences
PLSE
|
418 M | $ 14.04 | -1.44 % | $ 674 M | ||
|
Predictive Oncology
POAI
|
8.29 M | - | - | $ 32.4 M | ||
|
Repligen Corporation
RGEN
|
10.8 M | $ 158.66 | 0.81 % | $ 8.84 M | ||
|
Utah Medical Products
UTMD
|
247 M | $ 58.21 | 0.19 % | $ 211 M | ||
|
DENTSPLY SIRONA
XRAY
|
3.5 B | $ 11.38 | -1.69 % | $ 2.31 B | ||
|
Retractable Technologies
RVP
|
21 M | $ 0.84 | 2.04 % | $ 25.1 M | ||
|
Teleflex Incorporated
TFX
|
6.21 B | $ 126.36 | -0.24 % | $ 5.92 B | ||
|
West Pharmaceutical Services
WST
|
15.4 B | $ 270.21 | 0.99 % | $ 19.7 B |